TWD 15.95
(-0.31%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 163.09 Million TWD | 7.85% |
2022 | 151.22 Million TWD | 3.85% |
2021 | 145.62 Million TWD | -3.91% |
2020 | 151.55 Million TWD | 23.66% |
2019 | 122.55 Million TWD | 26.16% |
2018 | 97.14 Million TWD | 9.85% |
2017 | 88.43 Million TWD | 21.9% |
2016 | 72.54 Million TWD | 23.93% |
2015 | 58.53 Million TWD | 43.37% |
2014 | 40.82 Million TWD | -57.32% |
2013 | 95.65 Million TWD | 70.02% |
2012 | 56.26 Million TWD | 1677.04% |
2011 | 3.16 Million TWD | -42.91% |
2010 | 5.54 Million TWD | 606.5% |
2009 | 785 Thousand TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 151.6 Million TWD | -7.04% |
2024 Q2 | 160.96 Million TWD | 6.17% |
2023 Q3 | 180.03 Million TWD | 6.79% |
2023 Q4 | 163.09 Million TWD | -9.41% |
2023 FY | 163.09 Million TWD | 7.85% |
2023 Q1 | 166.08 Million TWD | 9.83% |
2023 Q2 | 168.59 Million TWD | 1.51% |
2022 Q3 | 159.88 Million TWD | 15.93% |
2022 Q2 | 137.91 Million TWD | 3.84% |
2022 FY | 151.22 Million TWD | 3.85% |
2022 Q1 | 132.81 Million TWD | -8.79% |
2022 Q4 | 151.22 Million TWD | -5.42% |
2021 Q1 | 157.85 Million TWD | 4.16% |
2021 Q2 | 128.57 Million TWD | -18.55% |
2021 FY | 145.62 Million TWD | -3.91% |
2021 Q3 | 156.49 Million TWD | 21.71% |
2021 Q4 | 145.62 Million TWD | -6.95% |
2020 FY | 151.55 Million TWD | 23.66% |
2020 Q3 | 146.72 Million TWD | 5.35% |
2020 Q1 | 138.76 Million TWD | 13.22% |
2020 Q2 | 139.28 Million TWD | 0.37% |
2020 Q4 | 151.55 Million TWD | 3.29% |
2019 Q1 | 92.1 Million TWD | -5.19% |
2019 Q3 | 113.19 Million TWD | 18.21% |
2019 Q4 | 122.55 Million TWD | 8.27% |
2019 FY | 122.55 Million TWD | 26.16% |
2019 Q2 | 95.76 Million TWD | 3.98% |
2018 Q2 | 95.84 Million TWD | -6.56% |
2018 Q3 | 95.55 Million TWD | -0.3% |
2018 Q4 | 97.14 Million TWD | 1.66% |
2018 Q1 | 102.56 Million TWD | 15.98% |
2018 FY | 97.14 Million TWD | 9.85% |
2017 Q1 | 73.67 Million TWD | 1.56% |
2017 FY | 88.43 Million TWD | 21.9% |
2017 Q4 | 88.43 Million TWD | 4.77% |
2017 Q3 | 84.4 Million TWD | -9.81% |
2017 Q2 | 93.57 Million TWD | 27.02% |
2016 Q2 | 52.32 Million TWD | 3.52% |
2016 Q1 | 50.54 Million TWD | -13.65% |
2016 FY | 72.54 Million TWD | 23.93% |
2016 Q3 | 61.91 Million TWD | 18.32% |
2016 Q4 | 72.54 Million TWD | 17.18% |
2015 Q2 | 36.18 Million TWD | -16.08% |
2015 FY | 58.53 Million TWD | 43.37% |
2015 Q4 | 58.53 Million TWD | 43.43% |
2015 Q3 | 40.81 Million TWD | 12.79% |
2015 Q1 | 43.11 Million TWD | 5.61% |
2014 Q2 | 71.29 Million TWD | -42.51% |
2014 Q1 | 124.01 Million TWD | 29.65% |
2014 Q3 | 70.81 Million TWD | -0.67% |
2014 Q4 | 40.82 Million TWD | -42.35% |
2014 FY | 40.82 Million TWD | -57.32% |
2013 Q1 | 81.37 Million TWD | 44.63% |
2013 Q3 | 113.17 Million TWD | 15.59% |
2013 Q2 | 97.9 Million TWD | 20.32% |
2013 FY | 95.65 Million TWD | 70.02% |
2013 Q4 | 95.65 Million TWD | -15.48% |
2012 Q2 | 8.36 Million TWD | 20.96% |
2012 FY | 56.26 Million TWD | 1677.04% |
2012 Q1 | 6.91 Million TWD | 118.35% |
2012 Q4 | 56.26 Million TWD | 34.57% |
2012 Q3 | 41.8 Million TWD | 399.99% |
2011 Q2 | 13.23 Million TWD | 87.99% |
2011 Q1 | 7.03 Million TWD | 26.9% |
2011 Q3 | 5.84 Million TWD | -55.8% |
2011 Q4 | 3.16 Million TWD | -45.86% |
2011 FY | 3.16 Million TWD | -42.91% |
2010 FY | 5.54 Million TWD | 606.5% |
2010 Q4 | 5.54 Million TWD | 0.0% |
2009 FY | 785 Thousand TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Grape King Bio Ltd | 737.18 Million TWD | 77.877% |
Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | 89.901% |
Maywufa Company Ltd. | 257.91 Million TWD | 36.765% |
ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | 89.21% |
Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 95.68% |
LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -168.156% |
YungShin Global Holding Corporation | 2.77 Billion TWD | 94.119% |
SCI Pharmtech, Inc. | 529.53 Million TWD | 69.201% |
Formosa Laboratories, Inc. | 1.59 Billion TWD | 89.791% |
PharmaEssentia Corporation | 1.45 Billion TWD | 88.819% |
Bora Pharmaceuticals Co., LTD. | 2.15 Billion TWD | 92.436% |